FF GENE BIOTECH
FF Gene Biotech was founded to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market.
Similar Organizations
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
More informations about "FF Gene Biotech"
News Release - Fulgent Genetics
FF Gene Biotech was founded in 2017 to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market. ... including its sales organization …See details»
Fulgent Genetics Announces Incremental Strategic Investment in …
May 10, 2021 FF Gene Biotech was founded in 2017 to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market. ... including its sales …See details»
FF Gene Biotech - PitchBook
When was FF Gene Biotech founded? FF Gene Biotech was founded in 2017. Where is FF Gene Biotech headquartered? FF Gene Biotech is headquartered in Fuzhou, China. What industry is …See details»
Fulgent Genetics, Inc. Announces Incremental Strategic Investment …
May 10, 2021 Fulgent Genetics, Inc. announced that the Company has made an incremental strategic investment in FF Gene Biotech, the Chinese entity formed in 2017 through a Joint …See details»
Fulgent Therapeutics acquires FF Gene Biotech - Crunchbase
May 10, 2021 FF Gene Biotech FF Gene Biotech was founded to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market. Acquiring …See details»
Fulgent Genetics Announces ~$19M Investment In Chinese Joint
Fulgent has made a cash investment of approximately $19.0 million in the Chinese entity, which gives Fulgent a majority stake and controlling ownership of FF Gene Biotech. FF Gene …See details»
FF Gene Biotech - Crunchbase
FF Gene Biotech was founded to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market. ... Experience the new Crunchbase, …See details»
FF Gene Biotech - Products, Competitors, Financials, Employees ...
FF Gene Biotech formed in 2017 through a Joint Venture between Fulgent Genetics, Xilong Scientific, and Fuzhou Jinqiang Investment Partnership (FJIP). Use the CB Insights Platform …See details»
Fulgent Genetics : to Invest $19 Million in Chinese Joint Venture, …
May 10, 2021 Fulgent Genetics said Monday it invested $19 million in genetic testing company FF Gene Biotech. This investment offers Fulgent a majority stake and controlling ownership of …See details»
Fulgent Genetics Announces Incremental Strategic Investment in
May 10, 2021 Fulgent has made a cash investment of approximately $19.0 million in the Chinese entity, which gives Fulgent a majority stake and controlling ownership of FF Gene …See details»
Fulgent Genetics Inc Locations - Headquarters & Offices
Shenzhen Fujin Gene Technology Co Ltd China. Fulgent Therapeutics LLC United States of America. Inform Diagnostics Inc United States of America ... FF Gene Biotech China. Fulgent …See details»
Fujian Fujun Gene Biotech Co., Ltd. announced that it expects to ...
May 9, 2021 FF Gene Biotech announced that it will receive $19,000,000 in an equity round of funding from returning investor Fulgent Genetics, Inc. on May 10, 2021. Post closing, the …See details»
Fulgent Genetics Invests Another $19 Million in China Testing JV
May 11, 2021 Fulgent Genetics of Los Angeles made a $19 million investment in its China JV, FF Gene Biotech, to gain majority control of the China testing company. In 2017, FF Gene was …See details»
Fulgent Genetics Makes $19M Investment in Chinese JV, Takes
May 10, 2021 Following its latest investment in FF Gene Biotech, Fulgent said it intends to increase testing capacity at the joint venture's Fujian-based facility and expand its sales …See details»
FF Gene Biotech - CB Insights
See FF Gene Biotech funding rounds, investors, investments, exits and more. Evaluate their financials based on FF Gene Biotech's post-money valuation and revenue. FF Gene Biotech …See details»
FF Gene Biotech - Updates, News, Events, Signals & Triggers
May 10, 2021 Edit Recent News & Activity Section. Acquisition • May 10, 2021. Fulgent Therapeutics acquired FF Gene Biotech for $19,000,000See details»
Fulgent Genetics Announces Incremental Strategic Investment
May 10, 2021 FF Gene Biotech was founded in 2017 to bring Fulgent Genetics’ Next Generation Sequencing (NGS) capabilities to the Chinese genetic testing market. The JV has enabled …See details»
Fulgent Genetics Reports Second Quarter Financial Results
Aug 9, 2021 Fulgent has purchased an incremental stake in the entity for approximately $19.0 million, giving Fulgent primary economic and operational ownership of FF Gene Biotech. FF …See details»
The most innovative biotech companies of 2025 - Fast Company
Mar 18, 2025 Why ALZpath, GeneDX, 10x Genomics, Protagonist Therapeutics, and Recursion are among the most innovative biotech companies of 2025. Best Workplaces for Innovators …See details»
Fulgent Genetics Announces Incremental Strategic Investment in …
May 10, 2021 Fulgent has made a cash investment of approximately $19.0 million in the Chinese entity, which gives Fulgent a majority stake and controlling ownership of FF Gene …See details»